Is Eli Lilly and Company overvalued?

Eli Lilly and Company (LLY) looks overvalued — trading about 52% above its fair value.

Overvalued

Price

$1220.51

Fair value

$580.61

Current P/E

53.2

Normal P/E

25.3

Market cap

$1.15T

Dividend yield

0.5%

Return on equity

92.6%

Sector

Healthcare

Fair value compares LLY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks